{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:10:10Z","timestamp":1746245410603,"version":"3.40.4"},"reference-count":54,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,5,2]]},"DOI":"10.1248\/bpb.b25-00011","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T22:07:31Z","timestamp":1746137251000},"page":"507-514","source":"Crossref","is-referenced-by-count":0,"title":["Tokishigyakukagoshuyushokyoto (TSGST) Inhibits Aggression Induced by Isolation Rearing in Mice"],"prefix":"10.1248","volume":"48","author":[{"given":"Honoka","family":"Nakajima","sequence":"first","affiliation":[{"name":"Division of Evaluation for Clinical Pharmacology, Faculty of Medical Pharmaceutical Sciences, Himeji Dokkyo University, 7\u20132\u20131 Kami-Ohno, Himeji, Hyogo 670\u20138524, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Division of Evaluation for Clinical Pharmacology, Faculty of Medical Pharmaceutical Sciences, Himeji Dokkyo University, 7\u20132\u20131 Kami-Ohno, Himeji, Hyogo 670\u20138524, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Yunusa I, El Helou ML. The use of risperidone in behavioral and psychological symptoms of dementia: a review of pharmacology, clinical evidence, regulatory approvals, and off-label use. <i>Front. Pharmacol.<\/i>, <b>11<\/b>, 596 (2020).","DOI":"10.3389\/fphar.2020.00596"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chen A, Copeli F, Metzger E, Cloutier A, Osser DN. The psychopharmacology algorithm project at the harvard south shore program: an update on management of behavioral and psychological symptoms in dementia. <i>Psychiatry Res.<\/i>, <b>295<\/b>, 113641 (2021).","DOI":"10.1016\/j.psychres.2020.113641"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) DeVane CL, Charles JM, Abramson RK, Williams JE, Carpenter LA, Raven S, Gwynette F, Stuck CA, Geesey ME, Bradley C, Donovan JL, Hall AG, Sherk ST, Powers NR, Spratt E, Kinsman A, Kruesi MJ, Bragg JE Jr. Pharmacotherapy of autism spectrum disorder: results from the randomized BAART clinical trial. <i>Pharmacotherapy<\/i>, <b>39<\/b>, 626\u2013635 (2019).","DOI":"10.1002\/phar.2271"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan AY. Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. <i>Pediatrics<\/i>, <b>137<\/b> (Suppl. 2), S124\u2013S135 (2016).","DOI":"10.1542\/peds.2015-2851K"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Salloum-Asfar S, Zawia N, Abdulla SA. Retracing our steps: A review on autism research in children, its limitation and impending pharmacological interventions. <i>Pharmacol. Ther.<\/i>, <b>253<\/b>, 108564 (2024).","DOI":"10.1016\/j.pharmthera.2023.108564"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Iasevoli F, Barone A, Buonaguro EF, Vellucci L, de Bartolomeis A. Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review. <i>Expert Opin. Drug Saf.<\/i>, <b>19<\/b>, 1419\u20131444 (2020).","DOI":"10.1080\/14740338.2020.1820985"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bobo WV, Cooper WO, Stein CM, Olfson M, Graham D, Daugherty J, Fuchs DC, Ray WA. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. <i>JAMA Psychiatry<\/i>, <b>70<\/b>, 1067\u20131075 (2013).","DOI":"10.1001\/jamapsychiatry.2013.2053"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Shinno H, Kamei M, Nakamura Y, Inami Y, Horiguchi J. Successful treatment with <i>Yi-Gan San<\/i> for rapid eye movement sleep behavior disorder. <i>Prog. Neuropsychopharmacol. Biol. Psychiatry<\/i>, <b>32<\/b>, 1749\u20131751 (2008).","DOI":"10.1016\/j.pnpbp.2008.06.015"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Mizukami K, Asada T, Kinoshita T, <i>et al<\/i>. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. <i>Int. J. Neuropsychopharmacol.<\/i>, <b>12<\/b>, 191\u2013199 (2009).","DOI":"10.1017\/S146114570800970X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K, Tsuchie K, Inagaki T, Horiguchi J. Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger\u2019s disorder: a 12-week prospective, open-label study. <i>BMC Psychiatry<\/i>, <b>12<\/b>, 215 (2012).","DOI":"10.1186\/1471-244X-12-215"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wake R, Miyaoka T, Furuya M, Hashioka S, Horiguchi J. Effects of yokukansan, a Japanese kampo medicine for symptoms associated autism spectrum disorder. <i>CNS Neurol. Disord. Drug Targets<\/i>, <b>15<\/b>, 551\u2013563 (2016).","DOI":"10.2174\/1871527315666160413120541"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Furukawa K, Tomita N, Uematsu D, <i>et al<\/i>. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer\u2019s disease. <i>Geriatr. Gerontol. Int.<\/i>, <b>17<\/b>, 211\u2013218 (2017).","DOI":"10.1111\/ggi.12696"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Okahara K, Ishida Y, Hayashi Y, Inoue T, Tsuruta K, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Yoshida K, Noda S, Tomita S, Fujimoto M, Hosomi J, Mitsuyama Y. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer\u2019s disease. <i>Prog. Neuropsychopharmacol. Biol. Psychiatry<\/i>, <b>34<\/b>, 532\u2013536 (2010).","DOI":"10.1016\/j.pnpbp.2010.02.013"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kaushik R, Morkovin E, Schneeberg J, Confettura AD, Kreutz MR, Senkov O, Dityatev A. Traditional Japanese herbal medicine yokukansan targets distinct but overlapping mechanisms in aged mice and in the 5xFAD mouse model of Alzheimer\u2019s disease. <i>Front. Aging Neurosci.<\/i>, <b>10<\/b>, 411 (2018).","DOI":"10.3389\/fnagi.2018.00411"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ikarashi Y, Iizuka S, Imamura S, Yamaguchi T, Sekiguchi K, Kanno H, Kawakami Z, Yuzurihara M, Kase Y, Takeda S. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats. <i>Biol. Pharm. Bull.<\/i>, <b>32<\/b>, 1701\u20131709 (2009).","DOI":"10.1248\/bpb.32.1701"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kawashima N. Kambakutaisoto treatment for children with night crying and arousal parasomnias developed during prolonged hospitalization for hematological and oncological diseases. <i>J. Child Neurol.<\/i>, <b>36<\/b>, 568\u2013574 (2021).","DOI":"10.1177\/0883073820984062"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Shiota A, Shime C, Nakai K, Kageyama M. \u201cKambakutaisoto\u201d and emotional instability associated with premenstrual syndrome. <i>Front. Nutr.<\/i>, <b>8<\/b>, 760958 (2021).","DOI":"10.3389\/fnut.2021.760958"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tsuda T, Kubota K, Yasuda K, Nishikawa S, Sugaya A, Sugaya E. Effects of Chinese herbal medicine \u201ckanbaku-taiso-to\u201d on transmembrane ionic currents and its local anesthetic action. <i>J. Ethnopharmacol.<\/i>, <b>17<\/b>, 257\u2013261 (1986).","DOI":"10.1016\/0378-8741(86)90113-3"},{"key":"19","unstructured":"19) Tsumura&amp; Co. \u201cTSUMURA Tokishigyakukagoshuyushokyoto Extract Granules for Ethical Use.\u201d &lt;https:\/\/pins.japic.or.jp\/pdf\/new\u200bPINS\/00001409.pdf&gt;, accessed in 31 January, 2025."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sarker SD, Nahar L. Natural medicine: the genus Angelica. <i>Curr. Med. Chem.<\/i>, <b>11<\/b>, 1479\u20131500 (2004).","DOI":"10.2174\/0929867043365189"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zhang C, Fan L, Fan S, Wang J, Luo T, Tang Y, Chen Z, Yu L. <i>Cinnamomum cassia<\/i> Presl: a review of its traditional uses, phytochemistry, pharmacology and toxicology. <i>Molecules<\/i>, <b>24<\/b>, 3473 (2019).","DOI":"10.3390\/molecules24193473"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of <i>Paeonia lactiflora<\/i> pall., a traditional chinese herbal medicine. <i>Front. Pharmacol.<\/i>, <b>2<\/b>, 10 (2011).","DOI":"10.3389\/fphar.2011.00010"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Gong LL, Yang S, Liu H, Zhang W, Ren LL, Han FF, Lv YL, Wan ZR, Liu LH. Anti-nociceptive and anti-inflammatory potentials of Akebia saponin D. <i>Eur. J. Pharmacol.<\/i>, <b>845<\/b>, 85\u201390 (2019).","DOI":"10.1016\/j.ejphar.2018.11.038"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kim SJ, Gao Zhang C, Taek Lim J. Mechanism of anti-nociceptive effects of <i>Asarum sieboldii<\/i> Miq. radix: potential role of bradykinin, histamine and opioid receptor-mediated pathways. <i>J. Ethnopharmacol.<\/i>, <b>88<\/b>, 5\u20139 (2003).","DOI":"10.1016\/S0378-8741(03)00181-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Shi Y, Wu D, Sun Z, Yang J, Chai H, Tang L, Guo Y. Analgesic and uterine relaxant effects of isoliquiritigenin, a flavone from <i>Glycyrrhiza glabra<\/i>. <i>Phytother. Res.<\/i>, <b>26<\/b>, 1410\u20131417 (2012).","DOI":"10.1002\/ptr.3715"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Singh A, Zhao K. Treatment of insomnia with traditional Chinese herbal medicine. <i>Int. Rev. Neurobiol.<\/i>, <b>135<\/b>, 97\u2013115 (2017).","DOI":"10.1016\/bs.irn.2017.02.006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Sobhani Z, Nikoofal-Sahlabadi S, Amiri MS, Ramezani M, Emami SA, Sahebkar A. Therapeutic effects of <i>Ziziphus jujuba<\/i> Mill. fruit in traditional and modern medicine: a review. <i>Med. Chem.<\/i>, <b>16<\/b>, 1069\u20131088 (2020).","DOI":"10.2174\/1573406415666191031143553"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Li M, Wang C. Traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the fruit of <i>Tetradium ruticarpum<\/i>: a review. <i>J. Ethnopharmacol.<\/i>, <b>263<\/b>, 113231 (2020).","DOI":"10.1016\/j.jep.2020.113231"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Naeimi M, Gorji N, Memariani Z, Moeini R, Kamalinejad M, Kolangi F. Gastroprotective herbs for headache management in Persian medicine: a comprehensive review. <i>J. Integr. Med.<\/i>, <b>18<\/b>, 1\u201313 (2020).","DOI":"10.1016\/j.joim.2019.11.004"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Nishida S, Eguchi E, Ohira T, Kitamura A, Kato YH, Hagihara K, Iso H. Effects of a traditional herbal medicine on peripheral blood flow in women experiencing peripheral coldness: a randomized controlled trial. <i>BMC Complement. Altern. Med.<\/i>, <b>15<\/b>, 105 (2015).","DOI":"10.1186\/s12906-015-0617-4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Lee K, Cho SG, Woo SM, Kim AJ, Lee KM, Go HY, Sun SH, Kim TH, Jung KY, Choi YK, Lim EM, Song YK, Park JH, Jun CY, Ko SG. Danggui-Sayuk-Ga-Osuyu-Senggang-Tang ameliorates cold-induced vasoconstriction <i>in vitro<\/i> and <i>in vivo<\/i>. <i>Mol. Med. Rep.<\/i>, <b>14<\/b>, 4723\u20134728 (2016).","DOI":"10.3892\/mmr.2016.5805"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Igarashi K, Kuchiiwa T, Kuchiiwa S, Iwai H, Tomita K, Sato T. Kamishoyosan (a Japanese traditional herbal formula), which effectively reduces the aggressive biting behavior of male and female mice, and potential regulation through increase of Tph1, Tph2, and Esr2 mRNA levels. <i>Brain Res.<\/i>, <b>1768<\/b>, 147580 (2021).","DOI":"10.1016\/j.brainres.2021.147580"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Tan O, Martin LJ, Bowen MT. Divergent pathways mediate 5-HT<sub>1A<\/sub> receptor agonist effects on close social interaction, grooming and aggressive behaviour in mice: exploring the involvement of the oxytocin and vasopressin systems. <i>J. Psychopharmacol.<\/i>, <b>34<\/b>, 795\u2013805 (2020).","DOI":"10.1177\/0269881120913150"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Wakabayashi C, Kiyama Y, Kunugi H, Manabe T, Iwakura Y. Age-dependent regulation of depression-like behaviors through modulation of adrenergic receptor \u03b1<sub>1A<\/sub> subtype expression revealed by the analysis of interleukin-1 receptor antagonist knockout mice. <i>Neuroscience<\/i>, <b>192<\/b>, 475\u2013484 (2011).","DOI":"10.1016\/j.neuroscience.2011.06.031"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Bibancos T, Jardim DL, Aneas I, Chiavegatto S. Social isolation and expression of serotonergic neurotransmission-related genes in several brain areas of male mice. <i>Genes Brain Behav.<\/i>, <b>6<\/b>, 529\u2013539 (2007).","DOI":"10.1111\/j.1601-183X.2006.00280.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) White SM, Kucharik RF, Moyer JA. Effects of serotonergic agents on isolation-induced aggression. <i>Pharmacol. Biochem. Behav.<\/i>, <b>39<\/b>, 729\u2013736 (1991).","DOI":"10.1016\/0091-3057(91)90155-U"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Negishi H, Sugahama S, Kawakamia A, Kondo J, Nishigaki Y, Yoshikawa M, Ueyama T, Ikeda K. Effect of <i>Angelica acutiloba<\/i> extract on blood flow regulation in stroke-prone spontaneously hypertensive rats. <i>Nat. Prod. Commun.<\/i>, <b>11<\/b>, 1497\u20131498 (2016).","DOI":"10.1177\/1934578X1601101018"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kim CM, Heo MY, Kim HP, Sin KS, Pachaly P. Pharmacological activities of water extracts of <i>Umbelliferae<\/i> plants. <i>Arch. Pharm. Res.<\/i>, <b>14<\/b>, 87\u201392 (1991).","DOI":"10.1007\/BF02857821"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Hariri M, Ghiasvand R. Cinnamon and chronic diseases. <i>Adv. Exp. Med. Biol.<\/i>, <b>929<\/b>, 1\u201324 (2016).","DOI":"10.1007\/978-3-319-41342-6_1"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. <i>Pharmacol. Ther.<\/i>, <b>207<\/b>, 107452 (2020).","DOI":"10.1016\/j.pharmthera.2019.107452"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Choi S, Jung MA, Hwang YH, Pyun BJ, Lee JY, Jung DH, Ji KY, Kim T. Anti-allergic effects of <i>Asarum heterotropoides<\/i> on an ovalbumin-induced allergic rhinitis murine model. <i>Biomed. Pharmacother.<\/i>, <b>141<\/b>, 111944 (2021).","DOI":"10.1016\/j.biopha.2021.111944"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Shaikh S, Ahmad K, Lim JH, Ahmad SS, Lee EJ, Choi I. Biological insights and therapeutic potential of <i>Glycyrrhiza uralensis<\/i> and its bioactive compounds: an updated review. <i>Arch. Pharm. Res.<\/i>, <b>47<\/b>, 871\u2013892 (2024).","DOI":"10.1007\/s12272-024-01522-0"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Chen L, Hu Y, Ye Z, Li L, Qian H, Wu M, Qin K, Li N, Wen X, Pan T, Ye Q. Major indole alkaloids in <i>Evodia rutaecarpa<\/i>: the latest insights and review of their impact on gastrointestinal diseases. <i>Biomed. Pharmacother.<\/i>, <b>167<\/b>, 115495 (2023).","DOI":"10.1016\/j.biopha.2023.115495"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Kuang X, She G, Ma T, Cai W, Zhao J, Liu B, Xu F. The pharmacology, pharmacokinetics, and toxicity of spinosin: a mini review. <i>Front. Pharmacol.<\/i>, <b>13<\/b>, 938395 (2022).","DOI":"10.3389\/fphar.2022.938395"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Matsuda T. Neuropharmacologic studies on the brain serotonin<sub>1A<\/sub> receptor using the selective agonist osemozotan. <i>Biol. Pharm. Bull.<\/i>, <b>36<\/b>, 1871\u20131882 (2013).","DOI":"10.1248\/bpb.b13-00645"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Iwasaki K, Satoh-Nakagawa T, Maruyama M, Monma Y, Nemoto M, Tomita N, Tanji H, Fujiwara H, Seki T, Fujii M, Arai H, Sasaki H. A randomized, observer-blind, controlled trial of the traditional Chinese medicine <i>Yi-Gan San<\/i> for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. <i>J. Clin. Psychiatry<\/i>, <b>66<\/b>, 248\u2013252 (2005).","DOI":"10.4088\/JCP.v66n0214"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Uchida N, Egashira N, Iwasaki K, Ishibashi A, Tashiro R, Nogami A, Manome N, Abe M, Takasaki K, Mishima K, Takata J, Oishi R, Nishimura R, Fujiwara M. Yokukansan inhibits social isolation-induced aggression and methamphetamine-induced hyperlocomotion in rodents. <i>Biol. Pharm. Bull.<\/i>, <b>32<\/b>, 372\u2013375 (2009).","DOI":"10.1248\/bpb.32.372"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Nishi A, Yamaguchi T, Sekiguchi K, Imamura S, Tabuchi M, Kanno H, Nakai Y, Hashimoto K, Ikarashi Y, Kase Y. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin<sub>1A<\/sub> receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan. <i>Neuroscience<\/i>, <b>207<\/b>, 124\u2013136 (2012).","DOI":"10.1016\/j.neuroscience.2012.01.037"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Yang Y, Zhao X, Zhu Z, Zhang L. Vascular dementia: a microglia\u2019s perspective. <i>Ageing Res. Rev.<\/i>, <b>81<\/b>, 101734 (2022).","DOI":"10.1016\/j.arr.2022.101734"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Rogers RL, Meyer JS, Mortel KF, Mahurin RK, Judd BW. Decreased cerebral blood flow precedes multi-infarct dementia, but follows senile dementia of Alzheimer type. <i>Neurology<\/i>, <b>36<\/b>, 1\u20136 (1986).","DOI":"10.1212\/WNL.36.1.1"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Dove D, Warren Z, McPheeters ML, Taylor JL, Sathe NA, Veenstra-VanderWeele J. Medications for adolescents and young adults with autism spectrum disorders: a systematic review. <i>Pediatrics<\/i>, <b>130<\/b>, 717\u2013726 (2012).","DOI":"10.1542\/peds.2012-0683"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Chen L, Zhang X, Hu C, Zhang Y, Zhang L, Kan J, Li B, Du J. Regulation of GABA<sub>A<\/sub> and 5-HT receptors involved in anxiolytic mechanisms of jujube seed: a system biology study assisted by UPLC-Q-TOF\/MS and RT-qPCR method. <i>Front. Pharmacol.<\/i>, <b>11<\/b>, 01320 (2020).","DOI":"10.3389\/fphar.2020.01320"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Tsutsui R, Shinomiya K, Sendo T, Kitamura Y, Kamei C. Effects of the 5-HT<sub>1A<\/sub> receptor agonist tandospirone on ACTH-induced sleep disturbance in rats. <i>Biol. Pharm. Bull.<\/i>, <b>38<\/b>, 884\u2013888 (2015).","DOI":"10.1248\/bpb.b14-00887"},{"key":"54","unstructured":"54) Hatakeyama H, Ouchi H, Inoue K, Shibano K, Hara K. Reversible cerebral vasoconstriction syndrome (RCVS) induced by a Chinese herbal medicine; tokishigyakukagoshuyushokyoto. <i>Brain Nerve<\/i>, <b>71<\/b>, 815\u2013819 (2019)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/5\/48_b25-00011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T03:29:38Z","timestamp":1746242978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/5\/48_b25-00011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00011","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"article-number":"b25-00011"}}